Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Belgium
Biotech
Belgium biotech Agomab seeks $212M Nasdaq debut
If Agomab sells shares at the top of its proposed range, the biotech would be valued at about $828 million.
Gabrielle Masson
Jan 29, 2026 10:13am
Cuts to the Bone: Orthopedic biotech slashes C-suite
Mar 29, 2022 11:27am
Belgian bio Precirix nabs $88M for radiopharmaceuticals in HER2
Mar 16, 2022 3:00am
Medtronic's Hugo surgical robot makes European debut
Feb 2, 2022 10:00am
New Galapagos CEO Stoffels jumps into deals, key hiring decision
Jan 27, 2022 12:00pm
FDA approval, partnership on agenda at Mithra as phase 3 hits
Jan 14, 2022 7:25am
